MBX MBX Biosciences, Inc.

Fundamentals / CIK 0001776111 / USD

MBX Biosciences, Inc. reported $500.6M in total assets and a net loss of $145.1M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MBX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$81.34MFY 2023 Net Income: -$32.56M2023FY 2024 Net Income: -$61.92M2024FY 2025 Net Income: -$87.00M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $79.16M $57.41M $28.53M
Total Operating Expenses $98.06M $68.19M $35.31M
Operating Income -$98.06M -$68.19M -$35.31M
EBITDA -$97.81M -$67.95M -$35.15M
Income Before Tax -$87.00M -$61.90M --
Income Tax Expense $0 $0 $0
Net Income -$87.00M -$61.92M -$32.56M
Basic EPS -$2.38 -$5.82 -$31.96
Diluted EPS -$2.38 -$5.82 -$31.96
Basic Shares Outstanding 36.5M 10.6M 1.0M
Diluted Shares Outstanding 36.5M 10.6M 1.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $32.05M $30.98M $18.47M $19.76M $19.27M $17.72M $22.41M $15.22M
Total Operating Expenses $66.34M $40.93M $27.27M $25.80M $23.93M $21.80M $26.53M $18.61M
Operating Income -$66.34M -$40.93M -$27.27M -$25.80M -$23.93M -$21.80M -$26.53M -$18.61M
EBITDA -$66.24M -$40.83M -$27.20M -$25.73M -$23.83M -$21.70M -$26.45M -$18.55M
Net Income -$62.42M -$37.09M -$23.52M -$22.09M -$21.62M -$19.41M -$23.88M -$15.59M
Basic EPS -$1.29 -$0.78 -$0.50 -- -$0.63 -$0.58 -$0.71 --
Diluted EPS -$1.29 -$0.78 -$0.50 -- -$0.63 -$0.58 -$0.71 --
Basic Shares Outstanding 48.6M 47.7M 46.6M -- 34.2M 33.4M 33.4M --
Diluted Shares Outstanding 48.6M 47.7M 46.6M -- 34.2M 33.4M 33.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $75.29M $49.35M $30.52M
Short-Term Investments $298.4M $212.8M $50.15M
Cash & Short-Term Investments $373.7M $262.1M $80.68M
Other Current Assets $861K $803K $133K
Total Current Assets $381.5M $267.3M $83.47M
Property, Plant & Equipment, Net $2.73M $1.08M $439K
Other Non-Current Assets $383K $50K $50K
Total Non-Current Assets $3.60M $1.25M $715K
Total Assets $385.1M $268.5M $84.18M
Accounts Payable $2.98M $5.33M $1.39M
Total Current Liabilities $15.49M $11.05M $3.93M
Total Non-Current Liabilities $426K $42K $365K
Total Liabilities $15.92M $11.09M $4.29M
Total Debt (incl. Leases) $596K $171K $324K
Common Stock $6.0K $5.0K $1.0K
Retained Earnings -$224.5M -$137.5M -$75.58M
Accumulated Other Comp. Income $286K $55K $60K
Total Stockholders' Equity $369.2M $257.4M -$72.47M
Total Equity $369.2M $257.4M -$72.47M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $161.7M $54.12M $45.21M $75.29M $223.1M $39.78M $29.90M $49.35M
Short-Term Investments $319.9M $364.5M $394.8M $298.4M $168.5M $185.1M $210.9M $212.8M
Cash & Short-Term Investments $481.6M $418.6M $440.0M $373.7M $391.7M $224.9M $240.8M $262.1M
Other Current Assets $2.48M $1.16M $814K $861K $882K $472K $626K $803K
Total Current Assets $492.8M $427.9M $448.5M $381.5M $397.5M $229.2M $244.3M $267.3M
Property, Plant & Equipment, Net $5.00M $4.66M $3.13M $2.73M $2.00M $1.73M $1.51M $1.08M
Other Non-Current Assets $247K $625K $579K $383K $50K $50K $50K $50K
Total Non-Current Assets $7.86M $8.05M $4.17M $3.60M $2.57M $2.33M $1.65M $1.25M
Total Assets $500.6M $435.9M $452.7M $385.1M $400.1M $231.5M $245.9M $268.5M
Accounts Payable $6.80M $4.36M $6.97M $2.98M $3.77M $5.76M $4.25M $5.33M
Total Current Liabilities $25.17M $23.66M $14.57M $15.49M $12.06M $11.76M $10.48M $11.05M
Total Non-Current Liabilities $2.50M $2.71M $378K $426K $476K $527K $23K $42K
Total Liabilities $27.67M $26.37M $14.95M $15.92M $12.54M $12.28M $10.50M $11.09M
Total Debt (incl. Leases) $3.29M $3.34M $555K $596K $623K $650K $130K $171K
Common Stock $6.0K $6.0K $6.0K $6.0K $6.0K $5.0K $5.0K $5.0K
Retained Earnings -$347.5M -$285.1M -$248.0M -$224.5M -$202.4M -$180.8M -$161.4M -$137.5M
Accumulated Other Comp. Income -$1.96M -$1.22M -$606K $286K $154K $11K $53K $55K
Total Stockholders' Equity $472.9M $409.5M $437.8M $369.2M $387.5M $219.2M $235.4M $257.4M
Total Equity $472.9M $409.5M $437.8M $369.2M $387.5M $219.2M $235.4M $257.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$86.97M -$61.92M -$32.56M
Depreciation & Amortization $248K $244K $157K
Stock-Based Compensation $8.68M $5.22M $2.04M
Change in Payables -$2.46M $3.93M $412K
Operating Cash Flow -$79.95M -$54.68M -$31.98M
Capital Expenditure -$1.93M -$874K -$129K
Free Cash Flow -$81.88M -$55.55M -$32.11M
Purchases of Investments -$358.1M -$239.5M -$63.80M
Investing Cash Flow -$83.70M -$160.6M -$30.93M
Common Stock Issued $601.7M -- --
Financing Cash Flow $189.6M $234.1M $69.22M
Net Change in Cash $25.94M $18.83M $6.31M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$62.42M -$37.09M -$23.52M -$22.06M -$21.62M -$19.41M -$23.88M -$15.59M
Depreciation & Amortization $100K $100K $64K $60K $100K $100K $77K $58K
Stock-Based Compensation $27.55M $6.06M $5.48M $2.66M $2.25M $1.94M $1.84M $1.49M
Change in Payables $3.17M -$3.23M $3.97M -$861K -$2.04M $2.01M -$1.56M $645K
Operating Cash Flow -$34.88M -$22.62M -$20.21M -$18.30M -$21.54M -$17.43M -$22.68M -$16.04M
Capital Expenditure -$1.19M -$901K -$437K -$793K -$399K -$707K -$30K -$92K
Free Cash Flow -$36.07M -$23.52M -$20.64M -$19.09M -$21.93M -$18.14M -$22.71M -$16.13M
Purchases of Investments -$29.73M -$53.89M -$154.2M -$205.4M -$46.40M -$47.43M -$58.89M -$87.50M
Investing Cash Flow $42.83M $29.21M -$97.10M -$130.0M $17.06M $25.99M $3.23M -$67.34M
Common Stock Issued -- $0 $688.8M -- -- -- -- --
Financing Cash Flow $99.61M $2.32M $87.44M $438K $187.8M $1.33M $4.0K -$132K
Net Change in Cash $107.6M $8.91M -$29.87M -$147.8M $183.3M $9.88M -$19.45M -$83.51M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -23.6% -24.1% --
Return on Assets (ROA) -22.6% -23.1% -38.7%
Current Ratio 24.62x 24.19x 21.26x
Quick Ratio 24.12x 23.72x 20.55x
Debt to Equity 0.00x 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -30.7% -25.5% -19.8% -23.6% -20.8% -35.1% -31.2% -24.1%
Return on Assets (ROA) -29.0% -23.9% -19.1% -22.6% -20.1% -33.3% -29.9% -23.1%
Current Ratio 19.58x 18.08x 30.79x 24.62x 32.95x 19.50x 23.31x 24.19x
Quick Ratio 19.14x 17.69x 30.21x 24.12x 32.47x 19.13x 22.97x 23.72x
Debt to Equity 0.01x 0.01x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001776111) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:21 UTC · Open in terminal